Table of Contents Global Molecular Diagnostics in Cancer Testing Market Professional Survey Report 2017 1 Report Overview 1.1 Definition and Specification 1.2 Report Overview 1.2.1 Manufacturers Overview 1.2.2 Regions Overview 1.2.3 Type Overview 1.2.4 Application Overview 1.3 Industrial Chain 1.3.1 Molecular Diagnostics in Cancer Testing Overall Industrial Chain 1.3.2 Upstream 1.3.3 Downstream 1.4 Industry Situation 1.4.1 Industrial Policy 1.4.2 Product Preference 1.4.3 Economic/Political Environment 1.5 SWOT Analysis 2 Market Analysis by Types 2.1 Overall Market Performance(Volume) 2.1.1 Type I Market Performance (Volume) 2.1.2 Type II Market Performance (Volume) 2.2 Overall Market Performance(Value) 2.1.1 Type I Market Performance (Value) 2.1.2 Type II Market Performance (Value) 3 Product Application Market 3.1 Overall Market Performance (Volume) 3.1.1 Application 1 Market Performance (Volume) 3.1.2 Application 2 Market Performance (Volume) 4 Manufacturers Profiles/Analysis 4.1 Abbott Molecular Diagnostics 4.1.1 Abbott Molecular Diagnostics Profiles 4.1.2 Abbott Molecular Diagnostics Product Information 4.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Performance 4.1.4 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.2 Accugenomics 4.2.1 Accugenomics Profiles 4.2.2 Accugenomics Product Information 4.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Business Performance 4.2.4 Accugenomics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.3 Agendia 4.3.1 Agendia Profiles 4.3.2 Agendia Product Information 4.3.3 Agendia Molecular Diagnostics in Cancer Testing Business Performance 4.3.4 Agendia Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.4 Ambry Genetics 4.4.1 Ambry Genetics Profiles 4.4.2 Ambry Genetics Product Information 4.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Performance 4.4.4 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.5 Biodesix 4.5.1 Biodesix Profiles 4.5.2 Biodesix Product Information 4.5.3 Biodesix Molecular Diagnostics in Cancer Testing Business Performance 4.5.4 Biodesix Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.6 bioMerieux 4.6.1 bioMerieux Profiles 4.6.2 bioMerieux Product Information 4.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Business Performance 4.6.4 bioMerieux Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.7 bioTheranostics (AviaraDx) 4.7.1 bioTheranostics (AviaraDx) Profiles 4.7.2 bioTheranostics (AviaraDx) Product Information 4.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Performance 4.7.4 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.8 Cancer Genetics 4.8.1 Cancer Genetics Profiles 4.8.2 Cancer Genetics Product Information 4.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Performance 4.8.4 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.9 Clarient, Inc. (GE Healthcare) 4.9.1 Clarient, Inc. (GE Healthcare) Profiles 4.9.2 Clarient, Inc. (GE Healthcare) Product Information 4.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Performance 4.9.4 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.10 Counsyl 4.10.1 Counsyl Profiles 4.10.2 Counsyl Product Information 4.10.3 Counsyl Molecular Diagnostics in Cancer Testing Business Performance 4.10.4 Counsyl Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.11 Flatiron Health 4.12 Epigenomics 4.13 Agendia 4.14 Ambry Genetics 4.15 Biodesix 5 Market Performance for Manufacturers 5.1 Global Molecular Diagnostics in Cancer Testing Capacity (K Units) and Market Share by Manufacturers 2013-2018 5.2 Global Molecular Diagnostics in Cancer Testing Sales (K Units) and Market Share by Manufacturers 2013-2018 5.3 Global Molecular Diagnostics in Cancer Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018 5.4 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 5.5 Global Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 5.6 Market Concentration 6 Regions Market Performance for Manufacturers 6.1 China Market Performance for Manufacturers 6.1.1 China Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.1.2 China Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.1.3 China Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.1.4 China Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.1.5 Market Concentration 6.2 USA Market Performance for Manufacturers 6.2.1 USA Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.2.2 USA Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.2.3 USA Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.2.4 USA Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.2.5 Market Concentration 6.3 Europe Market Performance for Manufacturers 6.3.1 Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.3.2 Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.3.3 Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.3.4 Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.3.5 Market Concentration 6.4 Japan Market Performance for Manufacturers 6.4.1 Japan Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.4.2 Japan Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.4.3 Japan Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.4.4 Japan Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.4.5 Market Concentration 6.5 Korea Market Performance for Manufacturers 6.5.1 Korea Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.5.2 Korea Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.5.3 Korea Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.5.4 Korea Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.5.5 Market Concentration 6.6 India Market Performance for Manufacturers 6.6.1 India Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.6.2 India Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.6.3 India Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.6.4 India Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.6.5 Market Concentration 6.7 Southeast Asia Market Performance for Manufacturers 6.7.1 Southeast Asia Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.7.2 Southeast Asia Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.7.3 Southeast Asia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.7.4 Southeast Asia Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.7.5 Market Concentration 6.8 South America Market Performance for Manufacturers 6.8.1 South America Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.8.2 South America Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.8.3 South America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.8.4 South America Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.8.5 Market Concentration 7 Global Molecular Diagnostics in Cancer Testing Market Performance (Sales Point) 7.1 Global Molecular Diagnostics in Cancer Testing Capacity (K Units) and Market Share by Regions 2013-2018 7.2 Global Molecular Diagnostics in Cancer Testing Sales (K Units) and Market Share by Regions 2013-2018 7.3 Global Molecular Diagnostics in Cancer Testing Revenue (M USD) and Market Share by Regions 2013-2018 7.4 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions 2013-2018 7.5 Global Molecular Diagnostics in Cancer Testing Gross Margin by Regions 2013-2018 8 Development Trend for Regions (Sales Point) 8.1 Global Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.2 China Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.3 USA Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.4 Europe Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.5 Japan Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.6 Korea Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.7 India Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.8 Southeast Asia Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 8.9 Southeast Asia Molecular Diagnostics in Cancer Testing Capacity and Growth, Sales Value and Growth Rate2013-2018 9 Development Trend for Regions (Sales Point) 9.1 Global Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.2 China Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.3 USA Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.4 Europe Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.5 Japan Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.6 Korea Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.7 India Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.8 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 9.9 South America Molecular Diagnostics in Cancer Testing Sales and Growth, Sales Value and Growth Rate2013-2018 10 Upstream Source, Technology and Cost 10.1 Upstream Source 10.2 Technology 10.3 Cost 11 Channel Analysis 11.1 Market Channel 11.2 Distributors 12 Consumer Analysis 12.1 Application 1 Industry 12.2 Application 2 Industry 13 Market Forecast 2019-2024 13.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024 13.1.1 Global Molecular Diagnostics in Cancer Testing Capacity (K Units) and Share by Regions 2019-2024 13.1.2 Global Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units) and Growth Rate 2019-2024 13.1.3 China Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.1.4 USA Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.1.5 Europe Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.1.6 Japan Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.1.7 Korea Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.1.8 India Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.1.9 Southeast Asia Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.1.10 South America Molecular Diagnostics in Cancer Testing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.3 Sales (K Units), Revenue (M USD) by Types 2019-2024 13.3.1 Overall Market Performance 13.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 13.4 Sales by Application 2019-2024 13.4.1 Overall Market Performance 13.4.2 Application 1 Sales and and Growth Rate 2019-2024 13.4.3 Application 2 Sales and and Growth Rate 2019-2024 13.5 Price (USD/Unit) and Gross Profit 13.5.1 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) Trend 2019-2024 13.5.2 Global Molecular Diagnostics in Cancer Testing Gross Profit Trend 2019-2024 14 Conclusion

List of Tables and Figures Figure Product Picture of Molecular Diagnostics in Cancer Testing Table Product Specifications of Molecular Diagnostics in Cancer Testing Table Manufacturers List in the Report Table Manufacturers Sales Market Share (%) 2013-2018 Table Regions Overview in 2017 Table Product Type and Standard Table Type Overview in 2017 Table Product Application and Standard Table Application Overview in 2017 Figure Industry Chain Structure of Molecular Diagnostics in Cancer Testing Table Industry News List of Molecular Diagnostics in Cancer Testing Figure New Project SWOT Analysis of Molecular Diagnostics in Cancer Testing Table Global Molecular Diagnostics in Cancer Testing Sales (K Units) by Types Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Types in 2013 Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Types in 2018 Table Type I Sales (K Units) and Growth Rate Figure Type I Sales (K Units) and Growth Rate Table Type II Sales (K Units) and Growth Rate Figure Type II Sales (K Units) and Growth Rate Table Global Molecular Diagnostics in Cancer Testing Revenue (M USD) by Types Figure Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Types in 2013 Figure Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Types in 2018 Table Type I Revenue (M USD) and Growth Rate Figure Type I Revenue (M USD) and Growth Rate Table Type II Revenue (M USD) and Growth Rate Figure Type II Revenue (M USD) and Growth Rate Table Global Molecular Diagnostics in Cancer Testing Sales (K Units) by Application 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table Application 1 Sales (K Units) and Growth Rate 2013-2018 Figure Application 1 Sales (K Units) and Growth Rate 2013-2018 Table Application 2 Sales (K Units) and Growth Rate 2013-2018 Figure Application 2 Sales (K Units) and Growth Rate 2013-2018 Table Abbott Molecular Diagnostics Profiles Table Abbott Molecular Diagnostics Product Information Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Accugenomics Profiles Table Accugenomics Product Information Table Accugenomics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Accugenomics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Accugenomics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Agendia Profiles Table Agendia Product Information Table Agendia Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Agendia Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Agendia Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Ambry Genetics Profiles Table Ambry Genetics Product Information Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Ambry Genetics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Biodesix Profiles Table Biodesix Product Information Table Biodesix Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Biodesix Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Biodesix Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table bioMerieux Profiles Table bioMerieux Product Information Table bioMerieux Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table bioMerieux Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table bioMerieux Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table bioTheranostics (AviaraDx) Profiles Table bioTheranostics (AviaraDx) Product Information Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Cancer Genetics Profiles Table Cancer Genetics Product Information Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Cancer Genetics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Clarient, Inc. (GE Healthcare) Profiles Table Clarient, Inc. (GE Healthcare) Product Information Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Counsyl Profiles Table Counsyl Product Information Table Counsyl Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Counsyl Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Counsyl Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Global Molecular Diagnostics in Cancer Testing Capacity (K Units) of Manufacturers 2013-2018 Table Global Molecular Diagnostics in Cancer Testing Capacity Market Share (%) of Manufacturers 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Capacity Market Share (%) in 2013 Figure Global Molecular Diagnostics in Cancer Testing Capacity Market Share (%) in 2018 Table Global Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Global Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Global Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Global Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Global Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table USA Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table USA Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure USA Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure USA Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table USA Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table USA Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure USA Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure USA Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table USA Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure USA Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure USA Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table USA Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure USA Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure USA Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure USA Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Europe Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Japan Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Japan Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Japan Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Japan Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Japan Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Japan Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Japan Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Japan Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Japan Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Japan Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Japan Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Japan Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Japan Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Japan Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Japan Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Korea Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Korea Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Korea Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Korea Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Korea Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Korea Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Korea Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Korea Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Korea Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Korea Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Korea Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Korea Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Korea Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Korea Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Korea Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table India Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table India Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure India Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure India Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table India Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table India Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure India Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure India Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table India Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure India Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure India Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table India Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure India Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure India Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure India Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Southeast Asia Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Southeast Asia Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table Southeast Asia Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Southeast Asia Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table Southeast Asia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Southeast Asia Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Southeast Asia Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table South America Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table South America Molecular Diagnostics in Cancer Testing Sales Market Share (%) of Manufacturers 2013-2018 Figure South America Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2013 Figure South America Molecular Diagnostics in Cancer Testing Sales Market Share (%) in 2018 Table South America Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table South America Molecular Diagnostics in Cancer Testing Revenue Market Share (%) of Manufacturers 2013-2018 Figure South America Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2013 Figure South America Molecular Diagnostics in Cancer Testing Revenue Market Share (%) in 2018 Table South America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure South America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure South America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table South America Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure South America Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure South America Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure South America Molecular Diagnostics in Cancer Testing Market Concentration 2013-2018 Table Top 3 Sales Market Share (%) 2013-2018 Table Top 5 Sales Market Share (%) 2013-2018 Table Top 8 Sales Market Share (%) 2013-2018 Table Global Molecular Diagnostics in Cancer Testing Sales (K Units) by Regions 2013-2018 Table Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Regions 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Regions in 2013 Figure Global Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Regions in 2018 Table Global Molecular Diagnostics in Cancer Testing Revenue (M USD) by Regions 2013-2018 Table Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions in 2013 Figure Global Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Regions in 2018 Table Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions in 2013 Figure Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Regions in 2018 Table Global Molecular Diagnostics in Cancer Testing Gross Margin by Regions 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Gross Margin by Regions in 2013 Figure Global Molecular Diagnostics in Cancer Testing Gross Margin by Regions in 2018 Figure Global Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Global Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure China Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure China Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure USA Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure USA Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Japan Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Japan Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure Korea Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure Korea Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018 Figure India Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2013-2018 Figure India Molecular Diagnostics in Cancer Testing Revenue (M USD) and Growth Rate 2013-2018

Abbott Molecular Diagnostics Accugenomics Agendia Ambry Genetics Biodesix bioMerieux bioTheranostics (AviaraDx) Cancer Genetics Clarient, Inc. (GE Healthcare) Counsyl Flatiron Health Epigenomics Exact Sciences Corporation Exiqon Genomic Health ...